The University of Vermont has named Richard L. Page, M.D., Dean of the Robert Larner, M.D. College of Medicine, as its inaugural Chief Medical Affairs Officer. In an increasingly complex environment around medicine and medical education, this role will help the university strengthen its strategic and material responsiveness to its land-grant mission and the well-being of the state.
Dr. Page will continue to serve as Dean of Larner, with oversight of more than 1,000 faculty members and nearly $100 million in research awards. In this capacity, he will report to Linda Schadler, UVM interim Provost and Senior Vice President. As Chief Medical Officer, Dr. Page will report to UVM President Marlene Tromp and serve as a member of the President’s Leadership Council. The latter will aid the university in sustaining and strengthening both cross-institutional collaboration with the University of Vermont Health Network, where he serves on the board of trustees, as well as the leadership team’s engagement with medical affairs, public health, and health care reform at the local, state, and national level.
“This appointment reflects the role of medical education and leadership in fostering partnerships and collaboration with health sciences researchers and health care professionals across our region and will allow us to more fully integrate the entire university’s academic strengths in those critical areas,” said Dr. Tromp. “Dr. Page is perfectly positioned to advance our public mission in the rapidly evolving world of medical care, education, and research. His breadth of experience in both academia and medicine will prove valuable not only to the university, but also to communities in Vermont and beyond.”
A tenured professor of medicine and nationally recognized cardiologist, Dr. Page has served as Dean at Larner since October 2018 and brings decades of leadership in academic medicine, clinical care, and cardiovascular research to this new role. He is a Fellow of the American Heart Association and the Heart Rhythm Society and an elected member of several distinguished medical societies. In addition, Dr. Page has authored more than 200 publications and articles and has served on numerous committees, including as Chair of the Circulatory Devices panel of the U.S. Food and Drug Administration.
Dr. Page holds a Doctor of Medicine and a Bachelor of Science in Zoology from Duke University. He completed his residency in Medicine at Massachusetts General Hospital in Boston, followed by research and clinical fellowships in Cardiology and Clinical Cardiac Electrophysiology at Duke University Medical Center. Prior to joining UVM, Dr. Page served as the George R. and Ellen Love Professor and Chair of the Department of Medicine at the University of Wisconsin School of Medicine and Public Health.
“I am grateful to serve UVM in this new capacity and look forward to working with Dr. Tromp and her leadership team,” said Dr. Page. “Amid the complex challenges confronting health care today, I see great opportunities for UVM to lead in patient-centered care, innovative education and biomedical research,” he said.
